Conference on medicine economy held in Nansha

The 36th Pharmaceutical Economic Information Conference is held in Nansha, Guangzhou, on May 13 and 14. [Photo/WeChat account: gz_nanshafabu]

The 36th Pharmaceutical Economic Information Conference, hosted by the National Medical Products Administration Institute of Medical Economics, took place in Nansha, Guangzhou, on May 13 and 14.

The conference centered on deepening medicine regulatory reforms, strengthening medicine safety, and fostering high-quality development across the pharmaceutical industry chain. Government officials, academicians, industry experts, and corporate leaders gathered to discuss key issues in the sector.

The Nansha Medicine and Medical Device Registration Guidance Service Workstation (Life Health Value Park Branch) was launched during the event. The workstation will operate through a government-enterprise collaboration model, guided by the Nansha market supervision and administration bureau. It aims to provide consultation and guidance on medicine, medical devices, and cosmetic product registrations, accelerating the market transformation of R&D achievements and boosting the biopharmaceutical industry in Nansha.

In recent years, Nansha's biopharmaceutical cluster has rapidly expanded, home to over 400 companies in cutting-edge fields such as innovative medicine and high-end medical devices. The district hosts national-level incubators like Guangdong Medical Valley, top-tier research institutions like the Hong Kong University of Science and Technology (Guangzhou), and 13 Guangzhou-based "Future Unicorn" innovators. 

The district plans to build a high-end biopharma "ecosystem", targeting niche sectors and industry-academia-medicine integration. With a 24-square-kilometer "One City, Three Valleys, Six Parks" industrial layout, Nansha will attract platform-level and flagship projects to strengthen its supply chain and innovation network.